文献速递甲状腺疾病

韩国多中心队列:甲状腺微小乳头状癌主动监测中肿瘤体积倍增时间预测疾病进展

Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
PubMed 文献 · Thyroid · 2021-08-03

该研究基于韩国多中心主动监测队列,分析326例甲状腺微小乳头状癌患者的肿瘤动力学。中位随访4.9年,17例(5.2%)出现最大径增加≥3毫米,9例(2.8%)发生新淋巴结转移。肿瘤体积倍增时间(TVDT)<5年是疾病进展(淋巴结转移和肿瘤增大)的独立危险因素。

要点

  • TVDT<5年与新发淋巴结转移显著相关(HR=6.51,95%CI 1.73-24.50,p=0.002)。
  • TVDT<5年与肿瘤增大显著相关(HR=20.89,95%CI 5.78-75.48,p<0.001)。
  • 主动监测早期测定TVDT有助于预测进展并调整随访强度。

核心结论

  • TVDT<5年是主动监测期间新发淋巴结转移和肿瘤增大的独立预测因素。
  • 早期测定TVDT有助于预测疾病进展、调整随访强度及决定是否需早期手术干预。

研究设计与样本

  • 韩国多中心长期随访队列研究,纳入326例甲状腺微小乳头状癌主动监测患者。
  • 中位随访4.9年,评估肿瘤体积变化和肿瘤体积倍增时间(TVDT)。

主要发现

  • 17例(5.2%,95%CI 2.7-7.6%)出现最大径增加≥3毫米,中位随访4.0年后。
  • 9例(2.8%,95%CI 1.0-4.5%)发生新淋巴结转移,中位随访2.2年后。
  • 新发淋巴结转移仅见于最大径增加≥3毫米的患者。
  • TVDT<5年组新发淋巴结转移率为7.4%,高于TV≥50%组的3.2%。
  • 仅TVDT<5年与淋巴结转移显著相关(p=0.002)。

关键数值与推荐

  • TVDT<5年预测新发淋巴结转移的HR=6.51(95%CI 1.73-24.50,p=0.002)。
  • TVDT<5年预测肿瘤增大的HR=20.89(95%CI 5.78-75.48,p<0.001)。

临床怎么用

  • 在主动监测早期测定TVDT,识别高危患者以调整随访频率。
  • TVDT<5年提示疾病进展风险高,可考虑更密切监测或早期手术干预。

局限性

  • 排除了54例(14.2%)随访时间短的患者,可能引入选择偏倚。
  • 延迟手术最常见原因为患者焦虑,可能影响主动监测的持续性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Some papillary thyroid microcarcinomas (PTMCs) may progress with tumor enlargement or development of new lymph node (LN) metastasis during active surveillance (AS). This study evaluated the relevant predictors of disease progression, especially new cervical LN metastasis. Methods: This was a long-term follow-up study conducted using a previous multicenter cohort of AS in Korea. After excluding 54 (14.2%) patients with a short follow-up duration, 326 PTMC patients were evaluated for tumor kinetics, including changes in tumor volume (TV) and TV doubling time (TVDT). Results: During a median follow-up duration of 4.9 years, 17 (5.2%, 95% confidence intervals [CI] 2.7-7.6%) patients showed a maximal diameter increase of ≥3 mm after a median of 4.0 years follow-up, while 9 (2.8%, CI 1.0-4.5%) developed new LN metastasis after a median of 2.2 years follow-up. New cervical LN metastasis occurred exclusively of a maximal diameter increase of ≥3 mm. The prevalence of new development of LN metastasis was higher in patients with TVDT <5 years (7.4%) than in those with TV ≥50% (3.2%). Furthermore, only TVDT <5 years was significantly associated with LN metastasis (p = 0.002). In univariate and multivariate analyses, TVDT <5 years was an independent risk factor for disease progression with respect to new development of LN metastasis (hazard ratio [HR] = 6.51, CI 1.73-24.50; p = 0.002) and tumor enlargement (HR = 20.89, CI 5.78-75.48; p < 0.001). Finally, 86 (22.6%) patients underwent delayed surgery, and the most common reason was patient anxiety. Conclusions: TVDT <5 years is a predictor of disease progression during AS in terms of new LN metastasis development as well as tumor enlargement. Determination of TVDT in the early phase of AS could help in predicting disease progression, tailoring follow-up intensity of AS and in determining if early surgical intervention is needed.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Jin M, Kim HI, Ha J, et al. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea. Thyroid. 2021. PMID: 34225475. doi:10.1089/thy.2021.0094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。